These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 12788892

  • 21. Cytokine-induced prostaglandin E2 production and cyclooxygenase-2 expression in dental pulp cells: downstream calcium signalling via activation of prostaglandin EP receptor.
    Chang MC, Chen YJ, Tai TF, Tai MR, Li MY, Tsai YL, Lan WH, Wang YL, Jeng JH.
    Int Endod J; 2006 Oct; 39(10):819-26. PubMed ID: 16948668
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Distinct roles of central and peripheral prostaglandin E2 and EP subtypes in blood pressure regulation.
    Yang T, Du Y.
    Am J Hypertens; 2012 Oct; 25(10):1042-9. PubMed ID: 22695507
    [Abstract] [Full Text] [Related]

  • 25. Molecular pharmacology of aromatase and its regulation by endogenous and exogenous agents.
    Brueggemeier RW, Richards JA, Joomprabutra S, Bhat AS, Whetstone JL.
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):75-84. PubMed ID: 11850210
    [Abstract] [Full Text] [Related]

  • 26. Prostaglandin E2 inhibits the phospholipase D pathway stimulated by formyl-methionyl-leucyl-phenylalanine in human neutrophils. Involvement of EP2 receptors and phosphatidylinositol 3-kinase gamma.
    Burelout C, Thibault N, Levasseur S, Simard S, Naccache PH, Bourgoin SG.
    Mol Pharmacol; 2004 Aug; 66(2):293-301. PubMed ID: 15266020
    [Abstract] [Full Text] [Related]

  • 27. Enhancement of activated beta1-integrin expression by prostaglandin E2 via EP receptors in isolated human coronary arterial endothelial cells: implication for the treatment of Kawasaki disease.
    Kajimoto M, Ichiyama T, Ueno Y, Shiraishi M, Hasegawa M, Furukawa S.
    Inflamm Res; 2009 Apr; 58(4):224-8. PubMed ID: 19169646
    [Abstract] [Full Text] [Related]

  • 28. Novel prostaglandin receptor modulators--part II: EP receptor modulators; a patent review (2002 - 2012).
    Flesch D, Merk D, Lamers C, Schubert-Zsilavecz M.
    Expert Opin Ther Pat; 2013 Feb; 23(2):233-67. PubMed ID: 23289354
    [Abstract] [Full Text] [Related]

  • 29. Prostaglandin E2 enhances neurotrophin-4 production via EP3 receptor in human keratinocytes.
    Kanda N, Koike S, Watanabe S.
    J Pharmacol Exp Ther; 2005 Nov; 315(2):796-804. PubMed ID: 16081678
    [Abstract] [Full Text] [Related]

  • 30. Aromatase and cyclooxygenases: enzymes in breast cancer.
    Brueggemeier RW, Richards JA, Petrel TA.
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):501-7. PubMed ID: 14623550
    [Abstract] [Full Text] [Related]

  • 31. In vivo intra-luteal implants of prostaglandin (PG) E1 or E2 (PGE1, PGE2) prevent luteolysis in cows. II: mRNA for PGF2α, EP1, EP2, EP3 (A-D), EP3A, EP3B, EP3C, EP3D, and EP4 prostanoid receptors in luteal tissue.
    Weems YS, Bridges PJ, Jeoung M, Arreguin-Arevalo JA, Nett TM, Vann RC, Ford SP, Lewis AW, Neuendorff DA, Welsh TH, Randel RD, Weems CW.
    Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):60-5. PubMed ID: 22120546
    [Abstract] [Full Text] [Related]

  • 32. Ghrelin and des-acyl ghrelin inhibit aromatase expression and activity in human adipose stromal cells: suppression of cAMP as a possible mechanism.
    Docanto MM, Yang F, Callaghan B, Au CC, Ragavan R, Wang X, Furness JB, Andrews ZB, Brown KA.
    Breast Cancer Res Treat; 2014 Aug; 147(1):193-201. PubMed ID: 25056185
    [Abstract] [Full Text] [Related]

  • 33. Expression of the prostaglandin E(2) (PGE(2)) receptor subtype EP(4) and its regulation by PGE(2) in osteoblastic cell lines and adult rat bone tissue.
    Weinreb M, Machwate M, Shir N, Abramovitz M, Rodan GA, Harada S.
    Bone; 2001 Mar; 28(3):275-81. PubMed ID: 11248657
    [Abstract] [Full Text] [Related]

  • 34. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
    Rubin GL, Zhao Y, Kalus AM, Simpson ER.
    Cancer Res; 2000 Mar 15; 60(6):1604-8. PubMed ID: 10749129
    [Abstract] [Full Text] [Related]

  • 35. EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries.
    Jadhav V, Jabre A, Lin SZ, Lee TJ.
    J Cereb Blood Flow Metab; 2004 Dec 15; 24(12):1305-16. PubMed ID: 15625406
    [Abstract] [Full Text] [Related]

  • 36. Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors.
    Petrucci G, De Cristofaro R, Rutella S, Ranelletti FO, Pocaterra D, Lancellotti S, Habib A, Patrono C, Rocca B.
    J Pharmacol Exp Ther; 2011 Feb 15; 336(2):391-402. PubMed ID: 21059804
    [Abstract] [Full Text] [Related]

  • 37. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
    Iwanaga K, Okada M, Murata T, Hori M, Ozaki H.
    J Pharmacol Exp Ther; 2012 Mar 15; 340(3):604-11. PubMed ID: 22138372
    [Abstract] [Full Text] [Related]

  • 38. Estrogen receptor-related receptor alpha mediates up-regulation of aromatase expression by prostaglandin E2 in prostate stromal cells.
    Miao L, Shi J, Wang CY, Zhu Y, Du X, Jiao H, Mo Z, Klocker H, Lee C, Zhang J.
    Mol Endocrinol; 2010 Jun 15; 24(6):1175-86. PubMed ID: 20351196
    [Abstract] [Full Text] [Related]

  • 39. Prostaglandin E₂ induced contraction of human intercostal arteries is mediated by the EP₃ receptor.
    Longrois D, Gomez I, Foudi N, Topal G, Dhaouadi M, Kotelevets L, Chastre E, Norel X.
    Eur J Pharmacol; 2012 Apr 15; 681(1-3):55-9. PubMed ID: 22342278
    [Abstract] [Full Text] [Related]

  • 40. Characterization of prostaglandin E(2) receptors and their role in 24,25-(OH)(2)D(3)-mediated effects on resting zone chondrocytes.
    Del Toro F, Sylvia VL, Schubkegel SR, Campos R, Dean DD, Boyan BD, Schwartz Z.
    J Cell Physiol; 2000 Feb 15; 182(2):196-208. PubMed ID: 10623883
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.